Novartis Explores Sale of Certain Ophthalmology Assets
To hone in on its growth areas, Novartis is looking to trim its ophthalmology portfolio and sell off some of its assets, according to a Bloomberg report published Tuesday.
Novartis Explores Sale of Certain Ophthalmology Assets Read More »
